SILLAR CLINICAL

Active

Public limited companyfounded 2018active for 8 yearsXavier De Cocklaan 66, 9831 Sint-Martens-Latem, Belgium15 active companies are registered at this addressKBO/BCE: BE 0692.746.878

Summary

SILLAR CLINICAL has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €85,117 and a net result of €9,029. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 21% of 2,070 sector peers (NACE 73, financial year 2025). The computed 12-month bankruptcy probability is 1.0% (low).

Risk analysisFollow Report Compare

SILLAR CLINICALActiveChecked score 66/100

Risk analysis Report Compare

Activity

Market research and public opinion polling

NACE 73200Other research and development on natural sciences NACE 72109

7th largest employer in Sint-Martens-Latem, Professional and technical services sector1 site

Size

≈ €1.3mturnover 2025, estimated

Staff: 5.9 FTE
Equity: €85,117
Profit: €9,029

Turnover estimated from the gross margin

Financial health

66 Healthy Checked score 2025

Bankruptcy probabilitywithin 12 months: 1.0%

Structure

2025 accounts 129 days early1 of 8 deeds summarised

Why 66raises risk1 of the last 3 lateEquity €85,117 (10.5% of total assets)Size: 5.9 FTE, total assets €811,427lowers riskSector: Advertising, market research and public relations activities (NACE 73)Show the evidence

Checked score

Score 2025

66 / 100

Healthy

Probability in this band: 0.55% to 1.5%

Financially better than 33% of its sector peers (NACE 73, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Weak

Solvency 35-2

equity 10.5% of total assets

Liquidity 38+2

short-term debt 38.5% · cash 4.9%

Profitability 40+4

return on assets 1.1%

Bankruptcy probability, 12 months

1.0% Low

0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (11,217 companies, NACE 73, micro)

Last 24 months 11-2024: 0.6% 12-2024: 0.6%● unchanged vs 11-2024 01-2025: 0.6%● unchanged vs 12-2024lowest value 02-2025: 0.6%● unchanged vs 01-2025 03-2025: 0.6%● unchanged vs 02-2025 04-2025: 0.6%● unchanged vs 03-2025 05-2025: 0.6%● unchanged vs 04-2025 06-2025: 0.7%▲ +0.1 percentage points vs 05-2025 07-2025: 0.7%● unchanged vs 06-2025 08-2025: 1.2%▲ +0.5 percentage points vs 07-2025 09-2025: 1.5%▲ +0.3 percentage points vs 08-2025 10-2025: 2.6%▲ +1.1 percentage points vs 09-2025 11-2025: 2.7%▲ +0.1 percentage points vs 10-2025 12-2025: 2.7%● unchanged vs 11-2025 01-2026: 3.3%▲ +0.6 percentage points vs 12-2025 02-2026: 3.3%● unchanged vs 01-2026 03-2026: 3.4%▲ +0.1 percentage points vs 02-2026highest value 04-2026: 1.0%▼ -2.4 percentage points vs 03-2026 05-2026: 1.0%● unchanged vs 04-2026 06-2026: 1.0%● unchanged vs 05-2026 07-2026: 1.0%● unchanged vs 06-2026 08-2026: 1.0%● unchanged vs 07-2026 09-2026: 1.0%● unchanged vs 08-2026 10-2026: 1.0%● unchanged vs 09-2026

Credit of up to €5,000 on 30-day terms is acceptable

Liquidity ample (current ratio 1.69, compared with 1.68 in 2024, above the usual 1.5; short-term debt: 38.5% and cash: 4.9% of total assets), but 89.5% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 73, micro): better than 20% on solvency, 22% on liquidity, 26% on profitability and 62% on growth.

The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Seven signals.

lowers riskraises riskneutral

1 of the last 3 late

NBB · filings

Equity €85,117 (10.5% of total assets)

NBB · annual accounts

Sector: Advertising, market research and public relations activities (NACE 73)

KBO

Size: 5.9 FTE, total assets €811,427

Companies of this size fail more often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Weak solvency vs sector

Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 2070 sector peers (2025).

NBB · sector comparison

Position among 2070 sector peers

Solvency

better than 21%

← weakest strongest →

Growing equity

Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.

NBB · annual accounts 2025

Equity per financial year

1819202122232425

2018 to 2025 · latest year €85,117

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-03-2026, 129 days ahead of the deadline.

NBB · 8 filings

Deviation from the deadline

2025

129 days early

2024

215 days late

2023

on the day

2022

10 days late

2021

31 days late

2020

3 days early

2019

37 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 12 days after the deadline; the sector median (NACE 73) for financial year 2024 is 6 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 10 August (4 of the last 5 filed years within 139 days of that day).

Companies Code · seven months

Where today falls in the filing period

29-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

24-03-2026 Annual accounts filedfinancial year 2025 · abbreviated…
03-03-2026 Annual accounts filedfinancial year 2024 · abbreviated…
18-02-2026 Resignation: Vanessa Parrein (director)Declaration · Director discharge ·…

Key points

Positive: 7th largest employer in Sint-Martens-Latem, Professional and technical services sectorin the Checked rankings No. 7 View
A director leftlatest change 31-10-2025 · 0 in office 1 left View
Total assets 20256 financial years filed €811,427 View

By topic

Financials

Financial year: 2025
Total assets: €811,427
Profit: €9,029
Solvency: 10.5%

Total assets▲ 25.5%

Net result

20182025

Go to Financials

Timeline

Events: 14
Since: 2019
Next accounts: by 31-07-2027

31-07-2024Annual accounts filed
31-12-2023Back to profit
31-12-2023Liquidity more than doubled

Go to Timeline

Company details

Sites: 1

Legal form: Public limited company
Activity: Market research and public opinion pollingNACE 73200
Founded: 21-03-2018
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Key facts about SILLAR CLINICAL

What is the company number of SILLAR CLINICAL?: 0692.746.878. In Belgium the VAT number is the company number with BE in front: BE 0692.746.878.
Where is SILLAR CLINICAL based?: The registered office is at Xavier De Cocklaan 66, 9831 Sint-Martens-Latem.Company details
What does SILLAR CLINICAL do?: According to the KBO register, the main activity is market research and public opinion polling (NACE 73200).
What is the legal form of SILLAR CLINICAL?: Public limited company (NV).
When was SILLAR CLINICAL founded?: On 21-03-2018.
Is SILLAR CLINICAL still active?: Yes, SILLAR CLINICAL is an active enterprise in the KBO register.
How many employees does SILLAR CLINICAL have?: On average 5.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of SILLAR CLINICAL?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is SILLAR CLINICAL profitable?: In financial year 2025, SILLAR CLINICAL made a profit of €9,029.
Where can I find the annual accounts of SILLAR CLINICAL?: SILLAR CLINICAL filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SILLAR CLINICAL due?: By 31-07-2027, for financial year 2026.Timeline